GlassScriptPrepare for your visit
Kamran Akram
Cardiovascular Disease · Orlando, FL · NPI 1235358557
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$559.11
in general payments reported to CMS, 2019-2025 · $245 in 2025
The $245 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Who reported paying
General payments only, top 6 by amount.
- Kestra Medical Technology Services, INC. $136.91
- Shockwave Medical, INC $100.00
- Zoll Services LLC (A/K/A Zoll Lifecor Corp) $62.48
- E.R. Squibb & Sons, L.L.C. $60.65
- Janssen Pharmaceuticals, INC $31.58
- Novartis Pharmaceuticals Corporation $28.94
Drugs and devices associated with these payments
Assure Wcd Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter Lifevest Camzyos Leqvio Injectafer Wavewriter Alpha Prime 16 Jot Dx Barostim Neo System Repatha Eliquis
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Kamran Akram listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/56437/kamran-akram